Form 8-K - Current report:
SEC Accession No. 0001299933-10-001025
Filing Date
2010-03-11
Accepted
2010-03-11 11:07:31
Documents
4
Period of Report
2010-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_36692.htm 8-K 12438
2 EX-99.1 exhibit1.htm EX-99.1 95729
3 EX-99.2 exhibit2.htm EX-99.2 16969
4 GRAPHIC e29360-1070958261256de99b_1.jpg GRAPHIC 26836
  Complete submission text file 0001299933-10-001025.txt   163834
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 10672810
SIC: 2834 Pharmaceutical Preparations